The Motley Fool··Jonathan PoncianoProsight Doubles Down on Nektar With $10M Bet Ahead of Phase 3 Launch
Prosight Management increased Nektar stake to $10.27M, making it its largest position ahead of Phase 3 trial launch for rezpegaldesleukin.
NKTRbiotechclinical trials